Skip to main content
Premium Trial:

Request an Annual Quote

Exact Sciences' Stock to Transfer to Nasdaq Capital Market

NEW YORK (GenomeWeb News) – Exact Sciences has been notified by the Nasdaq Listing Qualifications Panel that its stock will be transferred to the Nasdaq Capital Market from the Nasdaq Global Market beginning with the opening of trade on Friday, Nov. 28.
 
Though it is being transferred to the Nasdaq Capital Market, Exact Sciences said today that it currently does not meet listing requirements for that market. The Nasdaq panel agreed to list the shares on the Capital Market on a conditional basis while it conducts a review of information that it requested from Exact Sciences regarding the firm’s plans for regaining compliance with the listing requirements.
 
In August, Exact Sciences was notified by Nasdaq that its stock is subject to delisting because it has not regained compliance with exchange’s requirement of a minimum $50 million market capitalization.
 
Exact Sciences said that the panel may complete its review of the supplemental information in early December. The firm also noted that it cannot assure that the panel will continue the conditional listing of its shares on the Capital Market following the review.
 
Shares of Exact Sciences were down 5 percent at $.35 in early Wednesday trade.
The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.